0 items

in your cart

  • Search for Medications
  • Viewcart | Checkout
  • Manage Account
  • Click-to-Call  

Prescription Drug Search

Product Request Form

Alemtuzumab is currently not available.

Our suppliers are constantly updating their product inventory and availability status. If you would like us to notify you when Alemtuzumab becomes available, please fill out the form below.


*We value your privacy! We will never give, lease, sell or otherwise disclose your personal information. Period!

Search for a drug:


Browse Alphabetically:

A · B · C · D · E · F · G · H · I · J · K · L · M · N
O · P · Q · R · S · T · U · V · W · X · Y · Z · #

Information about GlobalPharmacyMeds.to

SSL Secured Website Certified Global Pharmacy Network Hacker Proof: Safe Shopping Experience 5th Anniversary 2002-2007

List of countries where we can ship Alemtuzumab:

  • Albania
  • Argentina
  • Armenia
  • Australia
  • Austria
  • Azerbaijan
  • Bangladesh
  • Belarus
  • Belize
  • Bermuda
  • Brazil
  • Bulgaria
  • Cook Islands
  • Cuba
  • Ecuador
  • Egypt
  • Finland
  • Georgia
  • Greece
  • Guadeloupe
  • Hungary
  • India
  • Indonesia
  • Iran
  • Iraq
  • Japan
  • Malta
  • Mauritius
  • Moldova, Republic of
  • Netherlands
  • New Zealand
  • Panama
  • Peru
  • Slovenia
  • Sri Lanka
  • Taiwan
  • Tonga
  • United Arab Emirates
  • United Kingdom, UK
  • United States, US
View All Countries

Latest news releases on Alemtuzumab:

Alemtuzumab - Wikipedia

Alemtuzumab is a medication used to treat chronic lymphocytic leukemia (CLL) and multiple sclerosis. In CLL has been used as both a first line and second line treatment. In MS it is generally only recommended if other treatments have not worked. It is given by injection into a vein.. It is a monoclonal antibody that binds to CD52, a protein present on the surface of mature lymphocytes, but not ...

Alemtuzumab - pro.medicin.dk

Alemtuzumab er et humaniseret monoklonalt antistof, der produceres ved rekombinant DNA-teknologi, og som genkender og binder sig til et glykoprotein, CD52, der findes på overfladen af lymfocytter, hvorved disse går til grunde.

Alemtuzumab (Lemtrada): Indications, Side Effects ...

Use alemtuzumab (lemtrada) as ordered by your doctor. Read all information given to you. Follow all instructions closely. It is given as an infusion into a vein over a period of time. Other drugs may be given to help with infusion side effects. Make ...

分子標的薬(アレムツズマブ〔ヒト化抗CD52 ...

【薬剤師監修・作成】「分子標的薬(アレムツズマブ〔ヒト化抗cd52モノクローナル抗体〕)」慢性リンパ性白血病のリンパ球などの免疫細胞上に発現しているcd52抗原というタンパク質に結合し、細胞溶解作用などにより抗腫瘍効果をあらわす薬|薬の作用機序や副作用、種類などを薬剤師監修 ...

LEMTRADA® (alemtuzumab) | Healthcare Professional Site

Cases of severe, including fatal, neutropenia have been reported within 2 months of LEMTRADA infusion. Mild to moderate decreases in platelet counts, starting at the time of alemtuzumab infusion have been reported. Consider additional monitoring in patients with medical conditions which predispose them to cardiovascular or pulmonary compromise.

Relapsing MS Infusion Treatment: LEMTRADA® (alemtuzumab)

are taking a medicine called Campath ® (alemtuzumab) have received a live vaccine in the past 6 weeks before receiving LEMTRADA or plan to receive any live vaccines. Ask your healthcare provider if you are not sure if your vaccine is a live vaccine; are pregnant or plan to become pregnant. LEMTRADA may harm your unborn baby.

Campath (Alemtuzumab): Uses, Dosage, Side Effects ...

DESCRIPTION. CAMPATH (alemtuzumab) is a recombinant DNA-derived humanized monoclonal antibody (CAMPATH-1H) directed against the 21–28 kD cell surface glycoprotein, CD52.CAMPATH-1H is an IgG1 kappa antibody with human variable framework and constant regions, and complementaritydetermining regions from a murine (rat) monoclonal antibody (CAMPATH-1G).

Alemtuzumab | Multiple Sclerosis Society UK

Alemtuzumab stops these cells from getting into your brain and spinal cord before they can damage the nerves there. Most people only need to take the drug twice, in two courses spaced a year apart from each other. It's given through a drip (known as an infusion) in hospital.

ALEMTUZUMAB | Drug | BNF content published by NICE

Following a review of alemtuzumab by the European Medicines Agency, a revised indication, additional contraindications (see Contraindications), and strengthened monitoring requirements before, during, and after treatment have been recommended.Healthcare professionals are advised that alemtuzumab should only be used for the treatment of patients with relapsing-remitting multiple sclerosis (RRMS ...

Lemtrada - pro.medicin.dk – information om medicin

Hos patienter, der behandles med alemtuzumab, skal vitale tegn, inkl. blodtryk, monitoreres før og løbende under infusion med alemtuzumab. Hvis der observeres klinisk signifikante ændringer i de vitale funktioner, bør seponering af infusionen og yderligere monitorering, inkl.

Customer Service
1-866-799-3435 (Use ref# 10786) | Contact Form
Copyright © 2020 GlobalPharmacyMeds.to All rights reserved. Disclaimer | Privacy Policy
Accepted Credit Cards and Payment: VISA, MASTERCARD and eCHECK